Summary
- Current Price
- As of today, CSTL price is $28.00, up +4.52% on
- Current Price All-Time High
- CSTL price is currently -74.00% below its historical high of $107.69 set on
- Market Cap
- CSTL current market cap is $855M, up +94.82% over the past 365 days
- Revenue
- CSTL current annual revenue is $344.23M, up +3.66% year-over-year
- Next Earnings
- The next earnings release for CSTL is on
Profile
| Metric | Value |
|---|---|
| Full Name | Castle Biosciences, Inc. |
| Ticker | NASDAQ: CSTL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | castlebiosciences.com |
| Employees | 784 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $28.00 | |
| Price, 1D Change | +4.52% | |
| $855M | ||
| - | ||
| - | ||
| 0.78 | ||
| $344M | ||
| Revenue, 1Y Change | +3.66% | |
| -$0.83 | ||
| EPS, 1Y Change | -233.64% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.83 | ||
| EPS Estimate | N/A | -$1.33 |
| EPS Est. Change | N/A | -59.94% |
| $344.23M | ||
| Revenue Estimate | N/A | $367.39M |
| Revenue Est. Change | N/A | +6.73% |
| Current Price | $28.00 | |
| Price Target | - | $40.00 |
| Price Tgt. Change | - | +42.86% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.40 | $0.62 | +56.45% | |
| -$0.84 | -$0.83 | +0.64% | |
| -$1.33 | N/A | -59.94% | |
| -$1.01 | N/A | -21.72% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $329.64M | $332.07M | +0.74% | |
| $336.62M | $344.23M | +2.26% | |
| $367.39M | N/A | +6.73% | |
| $401.36M | N/A | +16.60% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $28.00 | |
| $28.87 | ||
| $22.67 | ||
| $25.65 | ||
| $23.71 | ||
| $0.92 | ||
| 0.78 | ||
| $1.40 | ||
| 71.39 | ||
| 59.26% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $344.23M | ||
| -$0.83 | ||
| $0.00 | ||
| 68.66% | ||
| -$42.81M | ||
| -12.44% | ||
| -$24.16M | ||
| -7.02% | ||
| -$2.04M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.08 | ||
| 5.26 | ||
| 5.11 | ||
| - | ||
| 3 | ||
| 4.34 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 2.39 | ||
| 1.82 | ||
| -37.86 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $470.87M | ||
| $299.51M | ||
| $609.21M | ||
| $361.10M | ||
| $138.34M | ||
| $68.68M | ||
| $37.02M | ||
| $1.84M | ||
| $18.71M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $368.39M | ||
| $279.16M | ||
| $107.88M | ||
| $229.32M | ||
| $40.77M | ||
| $0.00 | ||
| -$5.36M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $64.35M | ||
| -$60.37M | ||
| -$6.96M | ||
| $36.02M | ||
| $28.33M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Roth Capital | ||
| BTIG | → | |
| Baird | → | |
| Canaccord Genuity | → | |
| Baird | → | |
| Guggenheim | → | |
| Lake Street | → | |
| Guggenheim | → | |
| Canaccord Genuity | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
Screeners with CSTL
FAQ
- What is the ticker symbol for Castle Biosciences, Inc.?
- The ticker symbol for Castle Biosciences, Inc. is NASDAQ:CSTL
- Does Castle Biosciences, Inc. pay dividends?
- No, Castle Biosciences, Inc. does not pay dividends
- What sector is Castle Biosciences, Inc. in?
- Castle Biosciences, Inc. is in the Healthcare sector
- What industry is Castle Biosciences, Inc. in?
- Castle Biosciences, Inc. is in the Diagnostics & Research industry
- What country is Castle Biosciences, Inc. based in?
- Castle Biosciences, Inc. is headquartered in United States
- When did Castle Biosciences, Inc. go public?
- Castle Biosciences, Inc. initial public offering (IPO) was on July 25, 2019
- Is Castle Biosciences, Inc. in the S&P 500?
- No, Castle Biosciences, Inc. is not included in the S&P 500 index
- Is Castle Biosciences, Inc. in the NASDAQ 100?
- No, Castle Biosciences, Inc. is not included in the NASDAQ 100 index
- Is Castle Biosciences, Inc. in the Dow Jones?
- No, Castle Biosciences, Inc. is not included in the Dow Jones index
- When was Castle Biosciences, Inc. last earnings report?
- Castle Biosciences, Inc.'s most recent earnings report was on July 30, 2026
- When does Castle Biosciences, Inc. report earnings?
- The next expected earnings date for Castle Biosciences, Inc. is November 2, 2026
Data Sources & References
- CSTL Official Website castlebiosciences.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1447362/000162828026012272/0001628280-26-012272-index.htm
- CSTL Profile on Yahoo Finance finance.yahoo.com/quote/CSTL
- CSTL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cstl